Selskabets formål er udvikling af produkter rettet mod smitsomme sygdomme og anden forretningsmæssig aktivitet beslægtet hermed.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | - | -49.2 mio. | 175.9 mio. | 162.5 mio. | 40 | |
CVR: 38879073
Secondary names: Bactolife Biotech A/S, Bactolife Biologics A/S, Bactolife Technologies A/S
Previous names: Bactolife ApS
Compared to 50 companies in Fremstilling af andre kemiske produkter i.a.n.
Comparison is based on industry median values
Companies in the same industry and area
CVR 36960914
CVR 37719609
CVR 29804621
CVR 46308697
CVR 43431102
SELFINVEST ApS registered with 5% ownership
MR BIOINVEST ApS registered with 5% ownership
Novo Holdings A/S registered with 20% ownership
Danmarks Eksport- og Investeringsfond registered with 5% ownership
registered with 20% ownership
Sara Sande joined the board
Sophia Andrea Helga Heyde joined the board
Donna Margaret Parr joined the board
Morten Aleksandr Engel left the board
companydata.dk